SCHEMBL13759366

SCHEMBL13759366

Cc1cccc(Nc2nc3c(N4CCCCC4)nc(CCCCc4ccccc4)nc3[nH]2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HTT P42858 1/20 0.43
NPY5R Q15761 2/20 0.41
GBA1 P04062 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
TAAR1 Q96RJ0 2/20 0.39
POLB P06746 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 2/20 0.37
USP2 O75604 1/20 0.37
CREBBP Q92793 1/20 0.37
TP53 P04637 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14412518 0.89 LMNA (0.41) LMNASMN1; SMN2HTTNPY5RGBA1
SCHEMBL13759304 0.87 GBA1 (0.46) LMNASMN1; SMN2HTTNPY5RGBA1
SCHEMBL14413078 0.80 LMNA (0.51) LMNASMN1; SMN2HTTNPY5RGBA1
SCHEMBL428798 0.80 MAPT (0.43) LMNASMN1; SMN2GBA1MEN1KMT2A
SCHEMBL429470 0.80 GBA1 (0.49) LMNASMN1; SMN2HTTGBA1MEN1
SCHEMBL427561 0.79 GBA1 (0.49) LMNASMN1; SMN2HTTGBA1MEN1
SCHEMBL430964 0.78 MAPT (0.46) LMNASMN1; SMN2HTTGBA1MEN1
SCHEMBL13759199 0.76 SLC29A1 (0.51) LMNASMN1; SMN2HTTGBA1MEN1
SCHEMBL13759290 0.74 MAPK1 (0.51) LMNASMN1; SMN2HTTMEN1KMT2A
SCHEMBL14412728 0.74 LMNA (0.44) LMNASMN1; SMN2HTTNPY5RGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009100406-A2 TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS SYNTA PHARMACEUTICALS CORP. (US) 2009-08-13 WO disclosed